GLP-1 Weight Loss for Insulin Resistance and Metabolic Health Many patients interested in GLP-1 therapy also struggle with insulin resistance, prediabetes, type 2 diabetes risk, abdominal weight gain, cravings, fatigue after meals, or difficulty losing weight despite eating less
The lyophilized format also supports accurate reconstitution and minimizes variability between experimental replicates
How Do I Get Started With the Medical Weight Loss Program
Baseline and ongoing monitoring: Before initiating GLP-1/GIP therapy, consider measuring baseline B12 levels, particularly in patients concurrently taking metformin, those with previous bariatric surgery, individuals following plant-based diets, or those with malabsorption conditions
When riboflavin supplementation is needed, an amount that is five to ten times the daily recommended amount is appropriate ( Reference Said, Ross, Shils, Shike, Ross, Caballero and Cousins 14 )
Good habits, metabolic care, and professional support keep the progress from fading